A STUDY OF MASOOD’S AND MODIFIED MASOOD’S CYTOLOGICAL SCORING SYSTEM IN CYTOLOGICAL DIAGNOSIS OF BREAST LESIONS.

Main Article Content

Chaithra H1
Geetha J P
Lokesh M R

Keywords

Non-proliferative breast disease, Proliferative breast disease, Breast carcinoma

Abstract

Fine Needle Aspiration Cytology (FNAC) is a reliable diagnostic tool to distinguish non-proliferative from proliferative breast lesions. The categorization of breast lesions is important in identifying  the women who are at risk for the development of breast cancer. So it is essential to segregate the breast lesions by using Masood's Scoring Index (MSI) and its modification (Modified Masood's scoring index; MMSI) based on cytomorphological examination further which helps in the prognosis and management.


Objectives:  This study analyses the effectiveness of MMSI over MSI and asses the concordance between cytological scoring and histopathology of breast lesions.


Methodology: A total of 105 patients were included in this prospective study done from June 2023 to May 2024 and the breast lesions were cytologically categorized by conventional and as per both MSI and MMSS criteria, followed by comparison to a histopathological examination, which was taken as a gold standard.


Results: The age of the patients ranged from 24 to 82


 years with a mean age of 42.3 ± 14.8 years. Predominently right-sided breast lesions were more common. The overall diagnostic accuracy of the cytological scoring was 98.7%, with 92.4% sensitivity and 100% specificity


Conculsion: Cytological grading system based on MMSS allowed accurate diagnosis compared to the standard histopathological diagnosis. It is essential to differentiate non-proliferative lesions from proliferative lesions as the line of treatment and prognosis varies

Abstract 147 | Pdf Downloads 23

References

1. Mridha AR, Iyer VK, Kapila K, Verma K. Value of Scoring System in classification of proliferative breast disease on fine needle aspiration cytology. Indian J Pathol Microbiol 2006; 49:334-40.
2. Sneige N, Staerkel GA. Fine needle aspiration Cytology of Ductal hyperplasia with and with out atypia and ductal carcinoma in situ. Hum Pathol 1994; 25:485-92.
3. . Dziura BR, Bonfiglio TA. Needle cytology of the breast: A study of the cells of benign and malignant ductal neoplasia. Acta Cytol 1979; 23:332-40
4. Bibbo M, Scheiber M, Cajulis R, Keebler CM, Wield GL Dowlatshashi K: Stereotactic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions. Acta Cytol. 1988, 32:193-201.
5. Zajdela A, De LaRiva LS, Ghossein NA: The relation of prognosis to the nuclear diameter of breast cancer cells obtained by cytologic aspiration. Acta Cytol. 1979, 23:75-80.
6. 6.Masood S, Frykberg ER, Mclellan GL: Prospective evaluation of radiologically detected fine needle aspiration biopsy of nonpalpable breast lesions. Cancer. 1990, 66:1480-7.
7. 7.Masood S. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions. Clin Lab Med. 2005;25(4):713–31
8. Nandini NM, Rekha TS, Manjunath GV. Evaluation of scoring system in cytological diagnosis and management of breast lesion with review of literature. Indian J Cancer. 2011;48(2):240–45.
9. 9.Takiar R, Srivastav A. Time trend in breast and cervix cancer of women in India - (1990-2003). Asian Pac J Cancer Prev APJCP. 2008;9(4):777–80.
10. 10.Zagorianakou P, Fiaccavento S, Zagorianakou N, Makrydimas G, Stefanou D, Agnantis NJ. FNAC: its role, limitations and perspective in the preoperative diagnosis of breast cancer. Eur J Gynaecol Oncol. 2005;26(2):143–49.